AN ACT TO MAKE CLARIFICATIONS REGARDING THE CONDITIONS IN WHICH A PHYSICIAN ASSISTANT OR NURSE PRACTITIONER MUST CONSULT WITH A SUPERVISING PHYSICIAN PRIOR TO PRESCRIBING A TARGETED CONTROLLED SUBSTANCE. SL 2021-70. Enacted July 2, 2021. Effective October 1, 2021.
Bill H 629 (2021)Summary date: Jul 2 2021 - View summary
Bill H 629 (2021-2022)Summary date: Apr 21 2021 - View summary
Amends GS 90-18.1 (authorizing physician assistants to prescribe medication) and GS 90-18.2 (authorizing nurse practitioners to prescribe medication) to change the circumstances under which physician assistants or nurse practitioners must consult with the supervising physician before prescribing a targeted controlled substance to include when the patient is being treated by a facility that primarily engages in the treatment of pain by prescribing narcotic medications (previously also include a facility that advertises in any medium for any type of pain management services). Effective October 1, 2021.